|Mr. Huan Qing Gu||CEO, MD & Director||239.55k||N/A||N/A|
|Mr. Chow-Yee Koh||CFO & Director||90k||N/A||1976|
|Ms. Elizabeth Spooner||Company Sec.||N/A||N/A||N/A|
Stemcell United Limited, together with its subsidiaries, engages in the sourcing, producing, marketing, and selling of traditional medicines in Australia, Singapore, Greater China, and Malaysia. Its products include Caulerpa Lentillifera, a sea grape extract; Dendrobium Officinale Kimura et Migo, an orchid; Resina, a Daemonorops Draco Blume extract; and Cannabis Sativa, an industrial hemp. The company has a collaboration agreement with Temasek Polytechnic of Singapore to conduct joint research on the application of plant stem cell technology to the cultivation and commercial farming of seagrapes in Singapore; collaboration with Yunnan Hongyi Agriculture Development Co Ltd; and collaboration agreement with the University of Science, Malaysia to study the cultivation of sea grapes through the use of land-based and urban farming techniques. The company was formerly known as On Q Group Limited and changed its name to Stemcell United Limited in September 2015. Stemcell United Limited was incorporated in 1984 and is headquartered in Sydney, Australia.
Stemcell United Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.